Enveric Biosciences reports EB-003 brain activity profile distinct from DMT in mouse study
ENVB•Enveric Biosciences said a preclinical mouse study found EB-003 altered cortical brain activity differently from DMT and did not trigger the epileptic-like activity or acute body spasms observed with DMT. The findings support evaluating brain-wave monitoring in the planned Phase 1 trial.
1. Mouse study findings
Enveric Biosciences reported preclinical mouse study results showing that EB-003 altered cortical brain activity with a profile distinct from psychedelic comparator DMT. EB-003 did not trigger the epileptic-like brain activity or acute body spasms observed with DMT.
2. Planned trial monitoring
The findings support evaluating brain-wave monitoring in the planned Phase 1 trial to assess drug effects and guide dose selection.
